Study of 3 Doses of ARD-0403 in Testosterone Deficient Men
NCT00597051
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
42
Enrollment
INDUSTRY
Sponsor class
Conditions
Hypogonadism
Interventions
DRUG:
ARD-0403
Sponsor
Ardana Bioscience Ltd